Myeloid derived suppressor cells and autoimmunity

被引：61
|
作者：
Boros, Peter [1 ]
Ochando, Jordi [2 ]
Zeher, Margit [3 ]
机构：
[1] Icahn Sch Med Mt Sinai, Dept Surg, Recanati Miller Transplant Inst, New York, NY 10129 USA
[2] Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10129 USA
[3] Univ Debrecen, Div Clin Immunol, Fac Med, H-4032 Debrecen, Hungary
来源：
HUMAN IMMUNOLOGY | 2016年 / 77卷 / 08期
关键词：
Myeloid derived suppressor cells; Type; 1; diabetes; Rheumatoid arthritis; SLE; Inflammatory bowel disease; REGULATORY T-CELLS; CENTRAL-NERVOUS-SYSTEM; RHEUMATOID-ARTHRITIS; ACTIVATED MONOCYTES; PERIPHERAL-BLOOD; SYNOVIAL-FLUID; MICE; DISEASE; MOUSE; DIFFERENTIATION;
D O I：
10.1016/j.humimm.2016.05.024
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Myeloid-derived suppressor cells are a heterogeneous group of immature myeloid cells with immunoregulatory function. When activated and expanded, these cells can suppress T cell functions via cell-to cell interactions as well as soluble mediators. Recent studies investigated the involvement of MDSC in autoimmune diseases. Some papers have described beneficial effect of MDSC during the course of autoimmune diseases, and suggest a potential role as a treatment option, while others failed to detect these effects. Their contributions to autoimmune diseases are not fully understood, and many questions and some controversies remain as to the expansion, activation, and inhibitory functions of MDSC. This review aims to summarize current knowledge of MDSC in autoimmune disorders. (C) 2016 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码：631 / 636
页数：6
相关论文
共 50 条
  • [21] Myeloid-derived suppressor cells in glioma
    Mirghorbani, Masoud
    Van Gool, Stefaan
    Rezaei, Nima
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2013, 13 (12) : 1395 - 1406
  • [22] Cysteine cathepsins in myeloid derived suppressor cells
    Jakos, T.
    Fonovic, U. Pecar
    Svajger, U.
    Pislar, A.
    Kos, J.
    FEBS OPEN BIO, 2019, 9 : 351 - 351
  • [23] Myeloid-Derived Suppressor Cells and Radiotherapy
    Jimenez-Cortegana, Carlos
    Galassi, Claudia
    Klapp, Vanessa
    Gabrilovich, Dmitry, I
    Galluzzi, Lorenzo
    CANCER IMMUNOLOGY RESEARCH, 2022, 10 (05) : 545 - 557
  • [24] EBV and myeloid-derived suppressor cells
    Sinha, Debottam
    Khanna, Rajiv
    BLOOD, 2021, 137 (02) : 148 - 150
  • [25] Myeloid Derived Suppressor Cells and Their Role in Diseases
    Kong, Y. Y.
    Fuchsberger, M.
    Xiang, S. D.
    Apostolopoulos, V.
    Plebanski, M.
    CURRENT MEDICINAL CHEMISTRY, 2013, 20 (11) : 1437 - 1444
  • [26] Myeloid-derived suppressor cells in transplantation
    Dilek, Nahzli
    van Rompaey, Nicolas
    Le Moine, Alain
    Vanhove, Bernard
    CURRENT OPINION IN ORGAN TRANSPLANTATION, 2010, 15 (06) : 765 - 768
  • [27] History of myeloid-derived suppressor cells
    Talmadge, James E.
    Gabrilovich, Dmitry I.
    NATURE REVIEWS CANCER, 2013, 13 (10) : 739 - U79
  • [28] Myeloid-Derived Suppressor Cells in Sepsis
    Lai, Dengming
    Qin, Chaojin
    Shu, Qiang
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [29] Defining myeloid-derived suppressor cells
    Akkari, Leila
    Amit, Ido
    Bronte, Vincenzo
    Fridlender, Zvi G.
    Gabrilovich, Dmitry I.
    Ginhoux, Florent
    Hedrick, Catherine C.
    Ostrand-Rosenberg, Suzanne
    NATURE REVIEWS IMMUNOLOGY, 2024, 24 (12) : 850 - 857
  • [30] Myeloid derived suppressor cells: Targets for therapy
    Waldron, Todd J.
    Quatromoni, Jon G.
    Karakasheva, Tatiana A.
    Singhal, Sunil
    Rustgi, Anil K.
    ONCOIMMUNOLOGY, 2013, 2 (04):
12345